Not exact matches
The company's «moon shot,» which Wadsworth estimates is 10 to 15 years out, would be printing entire
replacement organs
from a patient's own
cells.
As well as allowing the use of stem
cells grown
from established
cell lines, the technology could enable the creation of improved human tissue models for drug testing and potentially even purpose - built
replacement organs.
Da Cruz and his team grew
replacement RPE
cells from human embryonic stem
cells on a thin plastic scaffold, before transplanting the tissue into the back of each volunteer's eye.
Both diseases result
from the death of retinal
cells, a process that Lanza suspects can be slowed or even halted using stem -
cell - derived
replacements.
Diabetes researchers are considering various
replacements for insulin injections: Transplanting new pancreatic islet
cells that make insulin, coaxing the patient's own islets to regenerate, or treating diabetics early in the disease with immune - suppressing therapies to prevent their body
from destroying the rest of their pancreatic islets.
Their major hurdle: to come up with a
replacement for hemoglobin (an iron - enriched protein in red blood
cells that transports oxygen
from the lungs to the rest of the body) that can be directly introduced into the human circulatory system.
Because burgeoning teeth depend on information
from the budding embryonic jaw, work toward generating
replacement teeth
from dental stem
cells focuses on growing them in the desired location in the recipient's mouth — but scientists are not yet sure the adult jaw can provide the necessary signals to shape made - to - order teeth.
We know that mitochondria do more than simply power our
cells, but in a recent New Scientist piece, Robin Lovell - Badge
from the MRC National Institute for Medical Research in London explained why none of these «extra» functions are relevant to mitochondrial
replacement.
By flipping on three key genes in
cells from the lower stomach, scientists may have engineered a viable
replacement for those beta
cells.
HSCT is effectively used today as a form of «
replacement» therapy for patients with hard - to - treat blood cancers, providing healthy
cells from either the patient (autologous transplantation) or
from a donor (allogeneic transplantation) to better equip patients to fight the disease on their own.
But for
cell replacement therapy to realize its potential, I anticipate that scientists must solve the developmental code, the set of rules that govern the formation of tissues, organs, and beings
from the original single
cell — the zygote.
Alternatively, adult stem
cells from the patient might be reprogrammed to provide genetically identical
replacement tissue.
The result — the second such finding in the past year — suggests that similar
cells from human testicles might have similar powers, paving the way to creating
replacement tissue for men who have suffered damage
from heart attacks or other injuries and avoiding some of the controversy surrounding embryonic stem
cells (ESC).
The goal was to generate functional beta - like
cells from pancreatic alpha
cells, which may be the ideal source for beta
cell replacement.
The new approach builds on information gleaned
from developmental studies of embryonic stem
cells (see story # 16) and one day may be used to create healthy
replacements for harmed or diseased tissue.
Five to seven years down the road, he predicts, patients recovering
from spinal fusion or joint -
replacement operations will have some of their own fat
cells removed, processed, and implanted at the same time as other surgical procedures.
Researchers at the RIKEN Center for Developmental Biology in Kobe plan to generate
replacement retinal pigment epithelial
cells from iPS
cells generated
from patients suffering age - related macular degeneration.
Atala wondered whether it would instead be possible to remove bladder
cells from a patient and use them to grow a
replacement organ, thus eliminating the risk of transplant rejection.
On - demand
replacement body parts inched closer to reality with the announcement
from San Diego biotech company Organovo that its organ «printer» had created the first artificial blood vessel made entirely
from human
cells, with no synthetic scaffolding.
Although solar
cell technology for converting the sun's power into electricity has improved steadily in recent years, high costs and inefficiencies have kept it
from being a serious
replacement for fossil fuels.
«Skeletal muscle created
from stem
cells: Discovery is major step towards a stem
cell replacement therapy for Duchenne Muscular Dystrophy.»
To determine whether Langerhans
cells replenish by dividing in the skin or by recruiting
replacements from the bloodstream, pathologist Miriam Merad of Stanford University and colleagues surgically joined two mice so that they shared a blood supply.
Burn victims or those with spinal cord injuries might be provided with
replacement skin or nerve tissue grown
from their own body
cells.
For experiments requiring complete eye field
replacement (A and B), one half of the eye field was surgically removed
from wild - type, stage 15 (host) embryos, and replaced with the donor
cells from one half of an explant.
Cell therapy, as envisaged by the teams of I - Stem, is primarily based on the identification of experimental protocols that can specifically guide differentiation of pluripotent cells to a cell fate, which presents a interest for the replacement of the defective cell population from the patient (the striatal neurons for Huntington's disease, the cells of the retinal pigment epithelium for retinitis pigmentosa, keratinocytes for genodermatoses, et
Cell therapy, as envisaged by the teams of I - Stem, is primarily based on the identification of experimental protocols that can specifically guide differentiation of pluripotent
cells to a
cell fate, which presents a interest for the replacement of the defective cell population from the patient (the striatal neurons for Huntington's disease, the cells of the retinal pigment epithelium for retinitis pigmentosa, keratinocytes for genodermatoses, et
cell fate, which presents a interest for the
replacement of the defective
cell population from the patient (the striatal neurons for Huntington's disease, the cells of the retinal pigment epithelium for retinitis pigmentosa, keratinocytes for genodermatoses, et
cell population
from the patient (the striatal neurons for Huntington's disease, the
cells of the retinal pigment epithelium for retinitis pigmentosa, keratinocytes for genodermatoses, etc.).
Therefore, recovery
from organ damage requires the
replacement of a variety of distinct
cell types.
Thirdly, the current, almost universal dependency of organoid culture on the use of Matrigel as a
replacement for the function of the extracellular basement matrix in providing structural support and survival signals to the epithelial
cells hampers clinical application, considering its origin
from a mouse sarcoma
cell line, its poorly defined composition and its mechanical rigidity after plating.
Therefore, successful recovery
from blindness due to injury or disease will require the functional
replacement of multiple retinal
cell types.
I am excited by the ability of regenerative medicine to provide
replacement tissue made
from a patient's own
cells and what it can mean to the patient's recovery and long - term health.
Scientists publishing in the journal
Cell Stem
Cell have reported the production of functional human oocytes
from discarded genetic material, a process which they suggest could one day assist in fertility treatment or mitochondrial
replacement therapy.
In the long run, scientists hope to use organoids and induced pluripotent stem
cells to engineer tissue
replacements in patients suffering
from diseases that currently are treated with direct transplants of fetal tissue.
There are now multiple immunotherapies targeting clearance of alpha - synuclein
from the brain in early - stage clinical trials, and multiple trials underway or in the works on the next generation of
cell replacement therapies for dopaminergic neurons, including the TRANSEURO trial; the Summit4StemCell initiative, put together by Jeanne Loring — a researcher at The Scripps Research Institute who is exceptionally engaged with turning her research into therapies; a Japanese trial to be run by Jun Takahashi of Kyoto University in Japan (cf. here and here); and a trial centered at Memorial Sloan Kettering Cancer Center headed by
cell biologist Lorenz Studer.
These results, published today (December 12) in Nature Biotechnology, have implications for autologous transplantation — creating a
replacement tissue
from a patient's own
cells — something that older people are more likely to need, the authors noted.
In addition, we use our expertise to facilitate the development of functionally mature beta
cells from embryonic stem
cells for
cell replacement therapies of type 1 diabetes.
We could have
replacement tissues and organs that perfectly match the recipient because they were cloned
from their own
cells.
«Report on the National Eye Institute Audacious Goals Initiative:
Replacement of Retinal Ganglion
Cells from Endogenous
Cell Sources,» by Monica Vetter and Peter Hitchcock, Translational Vision Science & Technology, March 2017.
San Diego, January 8, 2015 — ViaCyte, Inc., a privately - held regenerative medicine company with the first stem
cell - derived islet
replacement therapy for the treatment of diabetes in clinical trials, has received a No Objection Letter
from Health Canada providing clearance to proceed with sites in Canada for the Company's Phase 1/2 clinical trial of its VC - 01TM product candidate.
We have focused on the less - studied
replacement of astrocytes, the major support
cell in the central nervous system, by generating astrocytes
from embryonic human glial precursor
cells using two different astrocyte differentiation inducing factors.
Paul Pendleton paid $ 7,000 for adult stem -
cell treatment to his left knee, which, he says, saved him
from a knee
replacement.
ViaCyte grows
replacement insulin - producing
cells from human embryonic stem
cells, which are placed in a semipermeable pouch.
To produce EBs, ES
cell colonies were removed
from feeder
cells using a detaching solution, which consisted of 0.25 % trypsin supplemented with 1 mg / ml collagenase IV, 1 mM CaCl2, and 20 % knockout serum
replacement (KSR; Invitrogen, Carlsbad, CA).
Various
cell types have been examined for use in RPE
cell replacement including immortalized
cell lines, such as the human RPE
cell line, ARPE19 [2], sheets of adult RPE [3], foetal RPE [4], RPE derived
from human embryonic stem
cells (HESC - RPE)[5]--[10] and many non-RPE
cells lines [11]--[15].
The Regenexx ® family of non-surgical stem
cell and blood platelet procedures offer next - generation injection treatments for those who are suffering
from knee pain or may be facing knee surgery or knee
replacement due to common injuries, arthritis, overuse and other conditions.
While other investigators are pursuing the creation of
replacement RGCs
from stem
cells, these researchers are identifying ways to integrate the new
cells into the eye's light processing circuitry.
Researchers are looking at ways to restore the number of functional beta
cells in patients with diabetes, pursuing both the
replacement of lost beta
cells and the protection of beta
cells from further damage.
Whole - body Induced
Cell Turnover (WICT) consists of the qualitative and quantitative coordination of targeted cell ablation with exogenous cell administration so as to effect the replacement of a patient's entire set of endogenous cells with exogenous cells (of the same quantity and cell type as the ablated endogenous cells they are replacing) derived from human pluripotent stem cells and directionally differentiated in vitro prior to their administrat
Cell Turnover (WICT) consists of the qualitative and quantitative coordination of targeted
cell ablation with exogenous cell administration so as to effect the replacement of a patient's entire set of endogenous cells with exogenous cells (of the same quantity and cell type as the ablated endogenous cells they are replacing) derived from human pluripotent stem cells and directionally differentiated in vitro prior to their administrat
cell ablation with exogenous
cell administration so as to effect the replacement of a patient's entire set of endogenous cells with exogenous cells (of the same quantity and cell type as the ablated endogenous cells they are replacing) derived from human pluripotent stem cells and directionally differentiated in vitro prior to their administrat
cell administration so as to effect the
replacement of a patient's entire set of endogenous
cells with exogenous
cells (of the same quantity and
cell type as the ablated endogenous cells they are replacing) derived from human pluripotent stem cells and directionally differentiated in vitro prior to their administrat
cell type as the ablated endogenous
cells they are replacing) derived
from human pluripotent stem
cells and directionally differentiated in vitro prior to their administration.
Apart
from the BMW Z4
replacement and born - again Toyota Supra, there's also been talk of a shared supercar
from both brands, as well as a hydrogen - powered BMW i3 using fuel -
cell tech co-developed with Toyota.
That implies that blood is leaking
from its circulation or body somewhere or pooling in an organ such as the spleen (one cause of splenomegaly) and that your pet still has the capacity to produce new red blood
cell replacements.
Replacement cell phones not purchased
from a cellular service provider's retail or online store
A lead engineer
from the Department of Energy whose team is testing fuel
cell cars said in 2011 that the potential appeal is that «these are full - function vehicles with no limitations on range or refueling rate so they are a direct
replacement for any vehicle.